Risk-Adapted Preemptive Tocilizumab Decreases Severe Cytokine Release Syndrome (CRS) after CTL019 CD19-Targeted Chimeric Antigen Receptor (CAR) T-Cell Therapy for Pediatric B-Cell Acute Lymphoblastic Leukemia (B-ALL)
- Resource Type
- Abstract
- Authors
- Myers, Regina M.; Kadauke, Stephan; Li, Yimei; Callahan, Colleen A.; Gladney, Whitney; Fitzgerald, Julie C.; Wray, Lisa; Leahy, Allison Barz; Baniewicz, Diane; Motley, Laura S.; McGuire, Regina; Shenoy, Vikram; Barrett, David M.; Teachey, David T.; Maude, Shannon L.; DiNofia, Amanda; Grupp, Stephan A.
- Source
- In Biology of Blood and Marrow Transplantation March 2020 26(3) Supplement:S39-S39
- Subject
- Language
- ISSN
- 1083-8791